<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/css/uswds.min.css">
    <link rel="stylesheet" href="/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/21CFR812.html">Part 812
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 812.25  Investigational plan.
                            </h3>
                            <p class="depth0">The investigational plan shall include, in the following order:</p><p class="depth1"><em>(a)</em> Purpose. The name and intended use of the device and the objectives and duration of the investigation.</p><p class="depth1"><em>(b)</em> Protocol. A written protocol describing the methodology to be used and an analysis of the protocol demonstrating that the investigation is scientifically sound.</p><p class="depth1"><em>(c)</em> Risk analysis. A description and analysis of all increased risks to which subjects will be exposed by the investigation; the manner in which these risks will be minimized; a justification for the investigation; and a description of the patient population, including the number, age, sex, and condition.</p><p class="depth1"><em>(d)</em> Description of device. A description of each important component, ingredient, property, and principle of operation of the device and of each anticipated change in the device during the course of the investigation.</p><p class="depth1"><em>(e)</em> Monitoring procedures. The sponsor's written procedures for monitoring the investigation and the name and address of any monitor.</p><p class="depth1"><em>(f)</em> Labeling. Copies of all labeling for the device.</p><p class="depth1"><em>(g)</em> Consent materials. Copies of all forms and informational materials to be provided to subjects to obtain informed consent.</p><p class="depth1"><em>(h)</em> IRB information. A list of the names, locations, and chairpersons of all IRB's that have been or will be asked to review the investigation, and a certification of any action taken by

any of those IRB's with respect to the investigation.</p><p class="depth2"><em>(i)</em> Other institutions. The name and address of each institution at which a part of the investigation may be conducted that has not been identified in paragraph (h) of this section.</p><p class="depth1"><em>(j)</em> Additional records and reports. A description of records and reports that will be maintained on the investigation in addition to those prescribed in subpart G.</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
